Investor's Business Daily7d agobullish
This Medical Technology Stock Claws Back To A Buy ZoneThis medical technology name has a patented method of drug delivery. Halozyme stock recently hit a record high with earnings due out soon.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
526last 24h
2505last 7d
477● bullish (7d)
253● bearish (7d)
197publishers
Zacks90d agobullish
ImmunityBio (IBRX) Reports Q1 Loss, Tops Revenue EstimatesImmunityBio (IBRX) delivered earnings and revenue surprises of -12.50% and +7.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?